Michael OestergaardResearch Fellow at Ionis Pharmaceuticals
Dr. Michael Østergaard is a Research Fellow at Ionis Pharmaceuticals with extensive knowledge of the properties and chemistry of oligonucleotides. He received his first oligonucleotide training at the Nucleic Acid Center at University of Southern Denmark and earned his Master in Chemistry in 2006. In 2010 he earned his Ph. D. at the University of Idaho exploring conformationally restricted nucleotides. Dr. Østergaard is a medicinal chemist at Ionis Pharmaceuticals conducting research to improve the properties of antisense oligonucleotides. Dr. Østergaard is a co-author on 45 peer-reviewed articles and inventor on 9 patents.